The Alliance for Connected Care is preparing stakeholder letters to the White House and Senate and House leadership urging them to put pressure on the U.S. Drug Enforcement Administration to extend for two years a pandemic-era waiver allowing providers to use telemedicine. Extending the waiver, currently set to end this year, would give the DEA time to create a long-sought registration process for those prescriptions.